FEMS-ASM Mäkelä-Cassell Travel Award for Early Career Scientists
The FEMS-ASM Award supports the reciprocal exchange of one member from each organization to present his/her research at the other organization’s main conference. It has been designed to benefit early career scientists from both organizations by giving them the opportunity to present their work overseas and experience the best of microbiology in the partner country.
These awards are to support travel and living costs of the grantee only.
ASM will select the member attending the FEMS Congress occurring in 2023. Applicants should be microbiologists active in research and be current PhD (or equivalent) student or recipient of PhD within the past five years. They should be members of ASM. The awardee will be selected from applicants whose abstract has been accepted for presentation.
Submit an abstract and travel award application via the abstract submission site for the meeting. Include the following documents when submitting:
- ASM Membership number
- CV, including list of publications
- Signed endorsement form
Past Winners of the Mäkelä-Cassell Awards
ASM-FEMS Mäkelä-Cassell Award Awardee | Laura Glendinning, PhD, Core Scientist (Research Fellow) in Genetics and Genomics at the University of Edinburgh
FEMS-ASM Mäkelä-Cassell Award Awardee | Suparna Mitra, University Academic Fellow at the Leeds Institute of Medical Research
FEMS-ASM Mäkelä-Cassell Award Awardee | Valerie de Anda, Postdoctoral Researcher at the University of Texas at Austin, USA
ASM-FEMS Mäkelä-Cassell Award Awardee | Mohd Zulkifli Salleh, Graduate Teaching Assistant at University of Manchester, UK
FEMS-ASM Mäkelä-Cassell Award Awardee | Kana Morinaga
ASM-FEMS Mäkelä-Cassell Award Awardee | Ajijur Rahman
FEMS-ASM Mäkelä-Cassell Award Awardee | Ember Morrissey
ASM-FEMS Mäkelä-Cassell Award Awardee | Francesca Turroni
FEMS-ASM Mäkelä-Cassell Award Awardee | Clayton Caswell
FEMS Yeast Research is proud to present this latest thematic issue on yeast pathogenesis and drug resistance. In the past few decades, genetics and genomics studies have uncovered traits underlying the pathogenicity and drug resistances of pathogenic yeast. However, we still have a lot to uncover about the complex mechanisms used by different species to thrive in the human host, and much to do to convert this knowledge into improved clinical treatments. This thematic issue highlights the importance of the diversity of genome-scale approaches to unravel the intricate nature of pathogenesis and drug resistance in pathogenic yeasts, bringing together a diverse range of fascinating views on antifungal drug resistance.